Basiliximab Completed Phase 4 Trials for Kidney Transplantation / Anesthetics Adverse Reaction Prevention

Indications	Status	Purpose	Phase
DBCOND0028022 (Kidney Transplantation) DBCOND0063557 (Anesthetics Adverse Reaction)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00284947	Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids	Basiliximab (DB00074) Mycophenolate mofetil (DB00688) Mycophenolic acid (DB01024) Prednisolone (DB00860) Prednisone (DB00635)